Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00792168 · ClinicalTrials.gov registry record · Phase 4
Physiologic Monitoring of Antidepressant Response
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT00792168 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 38 participants.
The verdict
NCT00792168, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
Primary: to identify physiologic indicators of venlafaxine treatment response using quantitative EEG (QEEG) cordance, and to determine if cordance changes are specifically associated with response to venlafaxine; Secondary: to determine if cordance changes early in the course (i.e., prior to improvement in clinical symptoms) of venlafaxine (or another antidepressant if venlafaxine is not clinically indicated for a particular patient) are predictive of later clinical response.
Interventions
- OTHER placebo
- DRUG venlafaxine (Effexor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 1996-11 |
| Est. Completion | 1998-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00792168
The ClinicalTrials.gov registry entry for NCT00792168 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00792168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00792168 about?
NCT00792168 is a clinical study titled "Physiologic Monitoring of Antidepressant Response". Primary: to identify physiologic indicators of venlafaxine treatment response using quantitative EEG (QEEG) cordance, and to determine if cordance changes are specifically associated with response to venlafaxine; Secondary: to determine if cordance changes early in the course (i.e., prior to improv...
What is the current status of trial NCT00792168?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 1996-11. Estimated completion is 1998-12.
What interventions are being tested in trial NCT00792168?
The interventions under investigation include: placebo (OTHER), venlafaxine (Effexor) (DRUG).
Who is sponsoring clinical trial NCT00792168?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.